Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Mirvat Alasnag Added: 2 years ago
In this short and practice focused review, Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, SA) highlights some of the late-breaking clinical trials presented atACC.22from an interventionalist perspective. Trials covered in detail include: 00:58: SODIUM-HF: Study of Dietary Intervention Under 100 Mmol in Heart Failure 01:46: GHATI: Improving STEMI Management Internationally: Two… View more
Author(s): Adrian P Banning Added: 2 years ago
In this interview, Professor Adrian Banning (John Radcliffe Hospital, Oxford, UK) discusses the five-year outcomes of the SYNTAX II trial. This study aims to evaluate the impact of new technologies in percutaneous coronary intervention (PCI) by comparing the outcomes of these procedures to the original SYNTAX trial. The study showed that PCI moved forward considerably in the last 5 years, it is… View more
Author(s): Antonio Gutierrez , Sunil V Rao Added: 3 years ago
Current evidence-based therapies for ischemic heart disease include antithrombotic and antiplatelet medications that reduce the risk for ischemic outcomes such as myocardial infarction and stroke.1 Given their mechanism of action, bleeding is a risk with these agents, especially when combined with invasive procedures.2 In addition to overt bleeding, clinical trials of antithrombotic strategies… View more
Job title: Professor of Medicine
Prof Duk-Woo Park is Professor in the Cardiovascular Medicine Division at Asan Medical Center, Seoul, Korea, and an Instructor in Medicine at the University of Ulsan College of Medicine.Prof Park has a particular interest in revascularization strategy (PCI vs. CABG for multivessel and left main disease), antiplatelet/antithrombotic strategey, transcatheter valve interventions (TAVR), major… View more
Job title: Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK
Dr Julian Strange is theDirector of the Cardiac Catheter Suite at the Bristol Royal Infirmary and Network lead for Acute Coronary Syndromes in Avon, Gloucester and Wiltshire. Dr Strange has experience with specialisation in interventional cardiology, cardiovascular MRI and pulmonary circulation. View more
Job title: Director of Complex PCI and CTO Programmes
DrMargaret McEntegartserves as the Director of Complex PCI and CTO programmes atColumbia University Irving Medical Center, New York, US. She also holds the role of Director of Cardiac Catheterization Laboratories at Columbia University Irving Medical Center / New York-Presbyterian Hospital. Before joining Columbia, DrMcEntegart served as a consultant interventional cardiologist at Golden… View more
Author(s): Rasha Al-Lamee , Christopher Rajkumar , Nazli Okumus Added: 5 months ago
AHA 2023 — Investigators of ORBITA-2 trial, Dr Rasha Al-Lamee and Dr Christopher Rajkumar (Imperial College London, UK) talked with CardioNerds Ambassador, Dr Nazli Okumus about the randomised, placebo-controlled trial (NCT03742050) that compared the effects of coronary angioplasty versus placebo procedure on symptoms of stable angina without background anti-anginal therapy at 12 weeks.The ORBITA… View more
Research Area(s) / Expertise:

Intervention

Coronary Interventions

Job title: Clinical Associate Professor and Senior Consultant
Dr Khung Keong Yeo is aClinical Associate Professor and Senior Consultant at theNational Heart Centre in Singapore. Dr Khung Keong graduated from the National University of Singapore, where he earned is Batchelor in Medicine and Surgery. He then travelled to the United States of America, where he gained his American Board of Internal Medicine Certifications in Internal Medicine from the… View more